Combination therapy with ciclosporin and etanercept in patients with psoriatic arthritis

Annals of the Rheumatic Diseases

Volumn 69, Issue 5, 2010, Pages 934-935

  D'Angelo, Salvatore ^a   Cutro, Maria Stefania ^a   Lubrano, Ennio ^b   Leccese, Pietro ^a   Mennillo, Gianna Angela ^a   Ferrara, Nicola ^b,c   Olivieri, Ignazio ^a  

^a SAN CARLO HOSPITAL   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF MOLISE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; CYCLOSPORIN A; ETANERCEPT;

ADD ON THERAPY; ADULT; AGED; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEPATITIS C; HUMAN; HYPERTENSION; LETTER; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; SIDE EFFECT; TREATMENT OUTCOME;

ADULT; AGED; ARTHRITIS, PSORIATIC; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PILOT PROJECTS; RECEPTORS, TUMOR NECROSIS FACTOR; TREATMENT OUTCOME;

EID: 77951600234     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2009.119446     Document Type: Letter

References (8)

1. Gladman DD, Antoni C, Mease P, et al. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 2005;64(Suppl 2):ii14-17.
2. Scarpa R, Ayala F, Caporaso N, et al. Psoriasis, psoriatic arthritis, or psoriatic disease? J Rheumatol 2006;33:210-212 (Pubitemid 43209292)
3. Ravindran V, Scott DL, Choy EH. A systematic review and meta-analysis of efficacy and toxicity of disease modifying antirheumatic drugs and biological agents for psoriatic arthritis. Ann Rheum Dis 2008;67:855-859 (Pubitemid 351829388)
4. Ritchlin CT, Kavanaugh A, Gladman DD, et al.; Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). Treatment recommendations for psoriatic arthritis. Ann Rheum Dis 2009;68:1387-1394
5. de Vlam K, Lories RJ. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study. Rheumatology (Oxford) 2006;45:321-324 (Pubitemid 43372848)
6. Fredricksson T, Petterson U. Severe psoriasis: oral therapy with a new retinoid. Dermatologica 1978;157:238-244 (Pubitemid 8387357)
7. Heuft-Dorenbosch L, Spoorenberg A, van Tubergen A, et al. Assessment of enthesitis in ankylosing spondylitis. Ann Rheum Dis 2003;62:127-132
8. Taylor W, Gladman D, Helliwell P, et al.; CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006;54:2665-2673 (Pubitemid 44205029)